ASH Preview: One Size Fits All Approach Is No Longer Justified In AML
This article was originally published in Scrip
Executive Summary
A key theme already emerging from this year's American Society for Hematology (ASH) annual meeting, to be held Dec. 5-8 in Orlando, Florida, is the rise of precision medicines for blood cancers.